HACKENSACK MERIDIAN HEALTH
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
Pediatric Head Lice Study Product Comparison
- First Posted Date
- 2014-08-11
- Last Posted Date
- 2016-07-29
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 97
- Registration Number
- NCT02213055
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
Stem Cell Transplantation for Sickle Cell Anemia
- Conditions
- Interventions
- First Posted Date
- 2013-06-14
- Last Posted Date
- 2022-11-07
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 30
- Registration Number
- NCT01877837
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
Correlation Between CPAP Compliance and Food Intake Timing
- Conditions
- First Posted Date
- 2013-05-13
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 50
- Registration Number
- NCT01851811
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
Preparing Caregivers for the Child Sexual Abuse Examination: Are Informational Leaflets Helpful?
- Conditions
- Interventions
- First Posted Date
- 2013-05-09
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 37
- Registration Number
- NCT01850407
A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531
- Conditions
- Interventions
- First Posted Date
- 2013-03-18
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 7
- Registration Number
- NCT01813227
- Locations
- 🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide
- Conditions
- Interventions
- First Posted Date
- 2012-11-08
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 21
- Registration Number
- NCT01723839
- Locations
- 🇺🇸
John Theurer Cancer Center at HackensackUMC, Hackensack, New Jersey, United States
Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens
- Conditions
- Interventions
- First Posted Date
- 2011-12-30
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 25
- Registration Number
- NCT01502085
- Locations
- 🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
Blood Conservation in Cardiac Surgery
- Conditions
- Interventions
- First Posted Date
- 2011-11-01
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- Hackensack Meridian Health
- Registration Number
- NCT01463345
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
PRO#0118: Decitabine Plus Mini Flu-Bu
- Conditions
- Interventions
- First Posted Date
- 2011-10-20
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 20
- Registration Number
- NCT01455506
- Locations
- 🇺🇸
Hackensack University Medical Center - John Theurer Cancer Center, Hackensack, New Jersey, United States
Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
- First Posted Date
- 2011-10-17
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 63
- Registration Number
- NCT01453088
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States